Synonyms: PegIntron® | Sylatron®
peginterferon alfa-2b is an approved drug (EMA (2000), FDA (2001))
Compound class:
Peptide
Comment: Peginterferon alfa-2b is a pegylated interferon protein. Conjugation with polyethylene glycol (PEG) is a strategy commonly used to protect peptide drugs from in vivo proteolytic breakdown to increase their biological half-life and duration of action.
Peginterferon alfa-2b is on the World Health Organisation's List of Essential Medicines. Click here to access the pdf version of the WHO's 21st Essential Medicines list (2019). |
For advanced searching click here to open chemical structure editor
Other Similar Sequences ![]() |
|
IFN-α1/13 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α10 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α14 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α16 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α17 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α2 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α21 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α4 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α5 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α6 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α7 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α8 {Sp: Human} |
TargetsInterferon-α/β receptor |
IFN-α2b (recombinant human) |